Phase I trial of continuously infused gemcitabine with CPT-11 for refractory hematologic malignancies.

Journal Article

Full Text

Duke Authors

Cited Authors

  • Rizzieri, DA; Gockerman, JP; Decastro, CM; Lilly, S; Foster, T; Adams, D; Moore, JO

Published Date

  • November 16, 2000

Published In

Volume / Issue

  • 96 / 11

Start / End Page

  • 216B - 216B

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0006-4971

Language

  • English